Caleres forecasts Q3 GAAP EPS of $0.62 to $0.70 while targeting full-year adjusted EPS of $1.50 to $1.65
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?
Key PointsiShares U.S. Healthcare ETF offers a more diversified portfolio and lower expense ratio than Invesco Biotechnology & Genome ETF.
American Healthcare REIT Executive Sells 2,000 Shares for $111,000
Key PointsThe transaction was valued at approximately $111,000.
Netskope (NTSK) Q2 2027 Earnings Call Transcript
ARR hit $899 million with 27% growth as AI security demand accelerates.
Why Sasol Stock Soared Nearly 10% Higher Today
Key PointsHe believes it can prosper with growth in a key category.
Gold rebounds above $4,400 on weaker Dollar, US PPI inflation data looms
Gold price (XAU/USD) recovers to near $4,400, snapping the three-day losing streak during the early Asian session on Thursday. The precious metal gains ground amid a weaker US Dollar (USD).
Why Pulse Biosciences Stock Popped Today
The medical device maker now has a new bull touting its growth potential.